Segami Corporation

What Segami Corporation does

Segami Corporation is a privately held U.S. medical device software company founded in 1989 and headquartered in Columbia, Maryland, with a regional office in Laval, Quebec, Canada. The company develops and sells the Oasis and Oasis V3 platforms, vendor-neutral nuclear medicine processing and reading workstations that integrate with all major SPECT/CT, PET/CT, and PET/CT/MR camera systems. The platform combines image reconstruction, multi-modality fusion, and quantitative clinical applications spanning cardiology (CardiacRequant, MUGA), neurology (CerQuant, DopaQuant, SISCOM), oncology (PET-CT-MR fusion, tumor tracking, SUV calculation, PERCIST), and general nuclear medicine (renal, hepatobiliary, gastroesophageal, lung SPECT, thyroid, lymphography, bone scan, shunt). The product architecture is a core workstation platform extended with modular clinical applications, including third-party integrations such as the Cedars-Sinai Cardiac Suite and Invia Corridor4DM.

Underlying technology relies on classical quantitative imaging algorithms — OSEM3D reconstruction with resolution recovery and depth-dependent PSF, Mutual Information co-registration, Fourier-based gated analysis, and atlas-based brain quantification — rather than modern machine learning. Oasis carries FDA 510(k) clearance, ISO 13485, MDSAP, EU MDR certification, a Health Canada license, and U.S. VA VistA Imaging approval.

Segami generates revenue primarily through annual software licensing/subscriptions to healthcare institutions, supplemented by professional services for installation, training, and support. Distribution follows a hybrid model combining direct enterprise field sales (driven by a "Request a Demo" conversion mechanism) with channel partners including distributors and OEMs. The company targets nuclear medicine, cardiology, neurology, and oncology departments at hospitals and imaging centers, with pricing delivered via quote-based enterprise engagements. The firm has 11-50 employees and operates with no disclosed external funding or parent company.

Name

Segami Corporation

Legal name

Segami Corporation

Website

https://segamicorp.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Segami Corporation is a privately held Columbia, Maryland medical device software company that develops and sells Oasis, a vendor-neutral nuclear medicine processing and reading workstation serving hospitals and imaging centers across cardiology, neurology, oncology, and general nuclear medicine departments globally.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)

akta.pro secondary industries

Teleradiology Platforms & Reading Workflow (HLACALAK), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ)

Keywords

• Nuclear medicine software
• Medical imaging workstations
• Vendor-neutral imaging
• Cardiac SPECT analysis
• Oncology imaging software

Headquarters

HQ city

Columbia

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Licenses and Subscriptions: Segami generates revenue through software licensing of the Oasis/Oasis V3 platform to healthcare institutions. The software is sold as a workstation solution for nuclear medicine processing and reading. Given the regulatory documentation (IFUs, 510k clearance) and enterprise sales motion, the model likely involves annual licenses or subscription-based arrangements with healthcare facilities.
2. Professional Services and Support: The company provides installation and support services as referenced in their privacy policy, suggesting revenue from implementation, training, and ongoing technical support services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Segami Corporation develops, manufactures, and sells the Oasis and Oasis V3 vendor-neutral nuclear medicine processing and reading workstation software. The platform enables healthcare institutions to process, reconstruct, fuse, and interpret diagnostic images from SPECT/CT, PET/CT, and PET/CT/MR systems regardless of camera manufacturer, with clinical modules spanning oncology, cardiology, neurology, and general nuclear medicine. The company also provides installation, training, and technical support services alongside its software licensing business.

Product overview

Segami Corporation offers Oasis and Oasis V3 as its flagship vendor-neutral nuclear medicine workstation—a single unified platform providing both image processing and reading capabilities across all nuclear medicine modalities. The product integrates modules for MultiModality imaging (PET-CT-MR fusion, SPECT-CT-MR, Lymphography, Bone Scan), Neurology (CerQuant, DopaQuant, SISCOM), Cardiology (CardiacRequant, MUGA), and General Nuclear Medicine (Gastrointestinal, Pulmonary, Endocrine, Genitourinary applications). Processing Tools include Quickviewer and Reconstruction applications. The architecture combines a core workstation platform with specialized clinical modules, enabling radiologists to interpret all nuclear medicine studies on a single unified platform regardless of camera vendor.

Differentiator

Problem solved

Functional benefit

Brands

• Oasis: Vendor-neutral nuclear medicine software for processing and interpreting diagnostic images from SPECT/CT, PET/CT, and PET/CT/MR systems
• Oasis V3

Products and services

• Oasis V3 Flagship vendor-neutral nuclear medicine workstation providing all-in-one image processing and reading for SPECT/CT, PET/CT, and PET/CT/MR systems. Streamlines study processing for technologists and assists radiologists in interpreting studies with precision across oncology, cardiology, neurology, and general nuclear medicine, integrating with all camera manufacturers via DICOM conformance.
• CardiacRequant Comprehensive vendor-neutral cardiac SPECT and SPECT/CT reconstruction application using ultra-fast GPU-based 3D OSEM3D algorithm with resolution recovery and collimator deblurring, including attenuation correction, scatter correction, and depth-dependent PSF for cardiology departments performing cardiac SPECT studies.
• MUGA Analysis Application for assessing global and regional measures of ventricular function, focusing on left ventricular performance at rest and during stress, featuring advanced Fourier analysis, tail-drop correction, flexible ROI options, and comprehensive calculations including LVEF, End-Diastolic Volume, Peak Ejection Rate, and Peak Filling Rate.
• CerQuant Multimodality brain quantification software using affine registration to the Montreal Neurological Institute atlas, providing quantitative and qualitative displays comparing to multiple normative databases to measure defects in over 100 functional areas of the brain, validated with FDG, HMPAO, and ECD tracers.
• DopaQuant Parkinson's imaging technology for DaTscan analysis providing automated reorientation, guided 3-plane anatomical alignment, striata analysis workflow, Z-Score analysis, color-coded Z-score maps, and specific/non-specific uptake ratios with age correction for neurology departments.
• PET-CT-MR Fusion Comprehensive PET/CT package for reviewing volumetric multi-modality data from all major vendors, supporting automatic co-registration using Mutual Information Algorithms or manual registration across PET, CT, MR, and SPECT images, including tumor tracking, SUV calculations, PERCIST assessment, and multi-study comparison for oncology programs.
• MI Register Next-generation co-registration tool using the Mutual Information algorithm for precise alignment of two volumetric datasets, supporting dual modality fusion combinations including SPECT/PET, SPECT/MRI, SPECT/CT, PET/MRI, and PET/CT for multi-modality image fusion.
• Renal Applications Comprehensive suite of renal applications including Renal, Renal Transplant, and Renal DMSA for analyzing kidney function and structure, with quantification of relative and absolute uptake, SPECT/CT display, dynamic uptake analysis, clearance measurements, ERPF, GFR, and glomerular filtration rate calculations.

Quantifiable outcome

• Vendor-neutral integration eliminates need for multiple vendor-specific workstations
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• Cedars-Sinai Medical CentercoreTechnology or IntegrationCedars-Sinai Cardiac Suite is fully integrated with Oasis, including Quantitative Gated SPECT (QGS) for automatic segmentation and wall motion analysis, Quantitative Perfusion SPECT (QPS) for perfusion analysis, and Quantitative Blood Pool SPECT (QBS) for gated blood pool quantification. The Cedars Cardiac Suite provides comprehensive myocardial perfusion study analysis integrated into the Oasis workflow.
• Invia Solutions (Corridor4DM)coreTechnology or IntegrationCorridor4DM is integrated as an optional third-party application for processing and multidimensional diagnostic review of cardiac emission tomography studies. 4DMSPECT provides comprehensive cardiac application for reviewing and quantitatively analyzing myocardial perfusion and gated blood pool SPECT nuclear medicine studies.
• Distributors and OEMscoreChannel Partner/ Reseller/ DistributorSegami has built a trusted reputation in molecular imaging through strong partnerships with distributors and OEMs. The company maintains a Partner Center for partners to access resources and manage relationships, indicating an active channel distribution model.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/SegamiCorp
• LinkedInlinkedin.com/company/segami-corporation
• Facebookfacebook.com/SegamiCorp

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Segami Corporation